Abstract:Cyclin A is required for cell cycle S phase entry, and its overexpression contributes to tumorigenesis. Release of pre-existing E2Fs from inactive complexes of E2F and hypophosphorylated retinoblastoma (RB) is the prevailing dogma for E2F transcriptional activation of target genes such as cyclin A. Here we explored the hypothesis that new synthesis of E2F-1 is required for insulin-like growth factor-I (IGF-I) to induce cyclin A accumulation and RB hyperphosphorylation, events that are targeted by tumor necrosis factor alpha (TNFalpha) to arrest cell cycle progression. We first established that IGF-I increases expression of cyclin A, causes hyperphosphorylation of RB, and augments the mass of E2F-1 in a time-dependent manner. As expected, E2F-1 small interfering RNA blocks the ability of IGF-I to increase synthesis of E2F-1. Most important, this E2F-1 small interfering RNA also blocks the ability of IGF-I to increase cyclin A accumulation and to hyperphosphorylate RB. We next established that TNFalpha dose-dependently inhibits IGF-I-induced phosphorylation of both RB and histone H1 by cyclin A-dependent cyclin-dependent kinases. Cyclin-dependent kinase 2 (Cdk2) mediates this suppression because co-immunoprecipitation experiments revealed that TNFalpha reduces the amount of IGF-I-induced cyclin A that binds Cdk2, leading to a reduction in Cdk2 enzymatic activity. TNFalpha antagonizes the ability of IGF-I to increase mass of both E2F-1 and cyclin A but not cyclin E or D1. The cytostatic property of TNFalpha is also shown by its ability to block IGF-I-stimulated luciferase activity of a cyclin A promoter reporter. Deletion of an E2F recognition site from this reporter eliminates the regulatory effects of both IGF-I and TNFalpha on cyclin A transcription, indicating the essential role of E2F-1 in mediating their cross-talk. Collectively, these results establish that TNFalpha targets IGF-I-induced E2F-1 synthesis, leading to inhibition of the subsequent accumulation in cyclin A, formation of cyclin A-Cdk2 complexes, hyperphosphorylation of RB, and cell cycle arrest.

Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1.

Nuclear Accumulation of Epidermal Growth Factor Receptor and Acceleration of G1/S Stage by Epstein–Barr-encoded Oncoprotein Latent Membrane Protein 1

Nuclear Translocation of EGF Receptor Regulated by Epstein-Barr Virus Encoded Latent Membrane Protein 1

RETRACTED: Nuclear Factor Kappa B (nfκb) Dependent Modulation of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) in Epidermal Growth Factor Receptor (EGFR) Promoter Activity

Epstein-Barr Virus Encoded LMP1 Regulates Cyclin D1 Promoter Activity by Nuclear EGFR and STAT3 in CNE1 Cells

Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.

E2F1 Transactivates IQGAP3 and Promotes Proliferation of Hepatocellular Carcinoma Cells Through IQGAP3-mediated PKC-alpha Activation.

Interaction of Tumor Necrosis Factor Receptor-Associated Factors with the Latent Membrane Protein 1 is Essential for Activation of Nf-Kappa B

Retracted: Nuclear Factor Kappa B (Nf Kappa B) Dependent Modulation Of Epstein-Barr Virus Latent Membrane Protein 1 (Lmp1) In Epidermal Growth Factor Receptor (Egfr) Promoter Activity (Retracted Article. See Vol 106, Pg 83, 2004)

Epithelial Growth Factor Receptor-Activated Nuclear Factor Κb Signaling and Its Role in Epithelial Growth Factor Receptor-Associated Tumors.

LCAT1 is an Oncogenic LncRNA by Stabilizing the IGF2BP2-CDC6 Axis

Tumor Necrosis Factor Α Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis

Nuclear Localization of TEF3-1 Promotes Cell Cycle Progression and Angiogenesis in Cancer

E2F1 Induces TINCR Transcriptional Activity and Accelerates Gastric Cancer Progression Via Activation of TINCR/STAU1/CDKN2B Signaling Axis.

CDT1, transcriptionally regulated by E2F2, promotes lung adenocarcinoma progression

TC1 (C8orf4) is involved in ERK1/2 pathway-regulated G1- to S-phase transition

Epstein–Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-κB p65 in human nasopharyngeal carcinoma cells

TdIF1: a putative oncogene in NSCLC tumor progression

TdIF1-LSD1 Axis Regulates Epithelial—Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer

LAMC2 Promotes EGFR Cell Membrane Localization and Acts As a Novel Biomarker for Tyrosine Kinase Inhibitors (tkis) Sensitivity in Lung Cancer

Epstein-barr Virus-Encoded Latent Membrane Protein 1 Activates NF-κ B Via a Mechanism Involving TRAF2 in Nasopharyngeal Carcinoma